Page 14 - Shimadzu’s Solutions for Impurities Analysis
P. 14

FDA Regulations on    Qualitative and Quantitative Analysis
         Residual Solvents
                             of Residual Solvents
          Headspace GC



            ˙  Residual Solvent Analysis in Pharmaceuticals Using the
              GC-2010 Plus with a Headspace Sampler

            ICH decisions are leading to a standardization of the Japanese     drug application (NDA) or abbreviated new drug application
            Pharmacopoeia, U.S. Pharmacopoeia, and European       (ANDA).
                                                                  Instead of testing the final pharmaceuticals, testing can be
            Pharmacopoeia analytical methods. For example, the USP   ɾ
            <467> Residual Solvents method for analysis of residual     performed on the pharmaceutical ingredients and
            solvents in pharmaceutical products in the U.S.       pharmaceutical additives.
                                                                  Apart from analysis methods listed in the USP <467>
            Pharmacopoeia (USP 32) has changed from the conventional   ɾ
            Organic Volatile Impurities method to a Residual Solvents     method, it is acceptable to use another analytical procedure
    FDA Regulations on
  Genotoxic Impurities
            method based on the analysis method in the European     correctly
            Pharmacopoeia. The FDA has issued the following       listed and revised according to the cGMP (standards for
            recommendations in the draft guidance, "Residual Solvents in     manufacturing control and quality control of
            Drug Products Marketed in the United States."         pharmaceuticals) requirements.
            ɾ                                                   The Shimadzu GC-2010 Plus meets these requirements and
              To sell products listed for the official analytical method in
              the United States they must meet the requirements of the   supports the analysis of residual solvents.
              USP <467> Residual Solvents method, regardless of any new




             ˙  The GC-2010 Plus with a Headspace Sampler Features

            ɾ                                                       and flow switching; Advanced Flow Technologies realize shorter
              Shimadzu's GC-2010 Plus is the next-generation gas
  Residual Solvents
    FDA Regulations on
              chromatograph offering highly reliable trace-level and     analysis cycles and improve productivity.
              high-speed analysis as well as excellent operability.  ɾ
                                                                  Easy-to-use features save time reduce total analysis costs.
              Best-in-class(*) high-sensitivity detectors (FPD and FID) ensure
            ɾ
              high-precision analytical results.                  (*) Based on our survey as of April 2009
            ɾ
              Shimadzu’s unique technologies for ultimate gas flow control






    FDA Regulations on
  Inorganic Impurities
                                              GC-2010 Plus
                                              Advanced Flow Technology Gas Chromatograph














                                      Operation Screen              Identification/Quantitation Screen
   Support from Shimadzu
                                                       LabSolution
                                                       Workstation for GC



      14
   9   10   11   12   13   14   15   16   17   18   19